Central Precocious Puberty: Treatment with Triptorelin 11.25 mg

Background. Few data are available on quarterly 11.25 mg GnRH analog treatment in central precocious puberty (CPP). Aim. To assess the efficacy of triptorelin 11.25 mg in children with CPP. Patients. 17 patients (16 females) with CPP (7.9 ± 0.9 years) were treated with triptorelin 11.25 mg/90 days....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chiocca, Elena, Dati, Eleonora, Baroncelli, Giampiero I., Cassio, Alessandra, Wasniewska, Malgorzata, Galluzzi, Fiorella, Einaudi, Silvia, Cappa, Marco, Russo, Gianni, Bertelloni, Silvano
Médium: Artigo
Jazyk:Inglês
Vydáno: The Scientific World Journal 2012
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3356708/
https://ncbi.nlm.nih.gov/pubmed/22645436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/2012/583751
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky